AstraZeneca PLC (AZN.L)


LSE - LSE Delayed Price. Currency in GBp
5,080.00+18.00 (+0.36%)
At close: 12:47 PM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open5,042.00
Prev Close5,062.00
Bid5,051.00 x 6100
Ask5,080.00 x 13000
Day's Range5,010.00 - 5,138.00
52wk Range3,680.00 - 5,505.00
1y Target EstN/A
Market Cap64.25B
P/E Ratio (ttm)29.03
BetaN/A
Volume2,378,967
Avg Vol (3m)2,799,716
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal10 minutes ago

    [$$] Pfizer Buys Part of AstraZeneca’s Antibiotics Business

    Pfizer said the deal would boost its stable of older products, some of which have lost patent protection.

  • Associated Press7 hours ago

    Business Highlights

    ___ The hidden risk to the economy in corporate balance sheets America's debt problem is showing up in an unexpected place: Corporate America. Of the $1.8 trillion in cash that's sitting in U.S. corporate ...

  • Pfizer on buying spree with AstraZeneca antibiotics deal
    Associated Press7 hours ago

    Pfizer on buying spree with AstraZeneca antibiotics deal

    TRENTON, N.J. (AP) — Drugmaker Pfizer Inc. is continuing its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan's base in lower-tax Ireland.